Northern Trust’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Northern Trust's DYN Position: Q3 2026 in Review
Northern Trust increased its Dyne Therapeutics (DYN) stake by 15% in Q3 2026, buying an estimated $4.49M and bringing the position to 1,473,398 shares worth $23.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1646.
Northern Trust first reported a position in DYN in Q4 2020 and has held it in 24 quarters since. The position peaked at $28.4M in Q2 2026. 268 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Northern Trust held 1,473,398 shares of Dyne Therapeutics worth $23.7M as of Q3 2026.
- Northern Trust bought 195,317 Dyne Therapeutics shares in Q3 2026, an estimated $4.49M.
- Dyne Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #1646 holding.
- Northern Trust first reported a position in Dyne Therapeutics in Q4 2020 and has held it in 24 quarters since.
- Northern Trust's Dyne Therapeutics position peaked at $28.4M in Q2 2026.
- 268 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.